Hadron Energy (HDRN) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
5 Oct, 2026Executive summary
Blank-check vehicle had no operating activity or revenue through June 30, 2025; Q2 and H1 net income came primarily from Trust Account investment income. No business-combination target had been selected.
Management cited substantial doubt about the ability to continue as a going concern, given limited cash outside the Trust Account and dependence on completing a business combination.
Financial highlights
Q2 2025 net income was $1.54M, including $2.13M Trust Account interest and dividend income, partly offset by $384,593 of operating expenses and $201,942 of warrant fair-value expense.
H1 2025 net income was $3.16M, including $4.23M Trust Account income, partly offset by $756,426 of operating expenses and $316,115 of warrant fair-value expense.
Cash and marketable securities in the Trust Account totaled $207.42M at June 30, 2025; cash outside the Trust Account was $610,700.
Outlook and guidance
Operating revenue is not expected before completion of an initial business combination; management expects higher public-company compliance and target due-diligence costs.
The search period is 21 months from the August 2024 offering; if no combination closes, public shares are to be redeemed and the vehicle liquidated.
If outside-Trust cash is insufficient for at least 12 months absent a combination, management plans to manage payment timing or seek additional Sponsor funding; external financing may not be available on acceptable terms.
Latest events from Hadron Energy
- Higher costs cut Q1 net income; merger closing hinges on cash, approvals and redemptions.HDRN
Q1 2026 - A $250 million blind-pool IPO pairs a 21-month deadline with steep dilution and conflicts.HDRN
Registration filing - A $250 million SPAC raise pairs a 24-month acquisition search with substantial dilution and conflicts.HDRN
Registration filing - IPO proceeds reached $200.0 million; a business-combination target remains unselected.HDRN
Q3 2024 - Trust interest drove SPAC income as the microreactor target remained loss-making and pre-commercial.HDRN
Q4 2025 - Trust interest lifted Q1 profit as target search and going-concern risks persist.HDRN
Q1 2025 - 25M-unit IPO filing amended solely to add exhibits, with a 3.75M-unit option.HDRN
Registration filing - $250M SPAC, no target selected, 24-month deadline and material dilution risks.HDRN
Registration filing - A microreactor commercialization plan meets a large resale overhang and acute funding risk.HDRN
Registration filing